Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to develop a complement system
targeted monoclonal antibody (mAb) to be used in treatment of subjects with chronic
autoimmune diseases.